J. L. Parker, Z. Y. Zhang, and R. Buckstein, “Clinical Trial Risk in Non-Hodgkin’s Lymphoma: Endpoint and Target Selection”, J Pharm Pharm Sci, vol. 14, no. 2, pp. 227–235, Jun. 2011.